Structures by: Jaskólski M.
Total: 21
1:2 molecular complex of 5,5-diethylbarbituric acid and acridine
C34H30N4O3
Chemical Communications (2002) 17 1830-1831
a=18.249(4)Å b=16.260(3)Å c=10.053(2)Å
α=90.00° β=111.47(3)° γ=90.00°
1:1 molecular complex of 5,5-diethylbarbituric acid and 1,10-phenanthroline
C20H20N4O3
Chemical Communications (2002) 17 1830-1831
a=12.656(3)Å b=7.0140(14)Å c=20.665(4)Å
α=90.00° β=98.31(3)° γ=90.00°
1:1 molecular complex of 5,5-diethylbarbituric acid and 1,3,5,7- hexamethylenetetramine
C14H24N6O3
Chemical Communications (2002) 17 1830-1831
a=10.866(2)Å b=13.263(3)Å c=22.634(5)Å
α=90.00° β=90.00° γ=90.00°
4,4-bis(4-hydroxyphenyl)cyclohexanone
C18H18O3
CrystEngComm (2003) 5, 78 447
a=14.391(3)Å b=20.228(4)Å c=9.782(2)Å
α=90.00° β=91.96(3)° γ=90.00°
4,4-bis(3-methyl-4-hydroxyphenyl)cyclohexanone
C20H22O3
CrystEngComm (2003) 5, 78 447
a=10.004(2)Å b=15.783(3)Å c=20.253(4)Å
α=90.00° β=94.79(3)° γ=90.00°
C148.7H226.7N8.7O42.1
C148.7H226.7N8.7O42.1
CrystEngComm (2014) 16, 18 3773
a=15.7322(4)Å b=24.0717(7)Å c=41.3778(12)Å
α=90.00° β=90.00° γ=90.00°
C133.5H197N8O37.5
C133.5H197N8O37.5
CrystEngComm (2014) 16, 18 3773
a=15.7322(4)Å b=24.0717(7)Å c=41.3778(12)Å
α=90° β=90° γ=90°
C260H264N24O40
C260H264N24O40
Acta Crystallographica Section B (2020) 76, 5
a=21.91(2)Å b=21.91(2)Å c=25.44(3)Å
α=90° β=90° γ=90°
2-Oxa-4-androsten-3,17-dione
C18H24O3
Acta Crystallographica Section B (2000) 56, 3 512-525
a=6.2321(3)Å b=9.9264(6)Å c=12.8120(8)Å
α=90.00° β=97.079(5)° γ=90.00°
2-Oxa-5-alpha-androstane-3,17-dione
C18H26O3
Acta Crystallographica Section B (2000) 56, 3 512-525
a=6.3180(4)Å b=6.4489(5)Å c=38.841(3)Å
α=90.00° β=90.00° γ=90.00°
17-Hydroxy-2-oxaandrost-4-ene-3-one
C18H26O3
Acta Crystallographica Section B (2000) 56, 3 512-525
a=14.241(2)Å b=9.4401(9)Å c=11.648(2)Å
α=90.00° β=90.00° γ=90.00°
6alpha-hydroxy-2-oxaandrost-4-ene-3,17-dione
C18H24O4
Acta Crystallographica Section B (2000) 56, 3 512-525
a=6.2214(7)Å b=12.0500(10)Å c=10.8880(10)Å
α=90.00° β=103.070(10)° γ=90.00°
6-hydroxy-2-oxa-5beta-androstane-3,17-dione
C18H26O4
Acta Crystallographica Section B (2000) 56, 3 512-525
a=6.3350(10)Å b=9.4820(10)Å c=27.245(6)Å
α=90.00° β=90.00° γ=90.00°
6,17-dihydroxy-2-oxaandrost-4-ene-3-one
C18H26O4
Acta Crystallographica Section B (2000) 56, 3 512-525
a=9.3361(7)Å b=9.6261(7)Å c=17.764(2)Å
α=90.00° β=90.00° γ=90.00°
2-Oxa-4-androsten-3,17-dione and 2-Oxa-6beta-hydroxy-4-androsten-3,17-dione
0.72(C18H24O4),0.28(C18H24O4)
Acta Crystallographica Section B (2000) 56, 3 512-525
a=6.2246(7)Å b=12.0140(10)Å c=10.9150(10)Å
α=90.00° β=103.090(10)° γ=90.00°
C14H19N2,C1N1S1
C14H19N2,C1N1S1
Acta Crystallographica Section B (1994) 50, 3 358-363
a=8.0330(10)Å b=22.770(6)Å c=8.1930(10)Å
α=90.° β=90.° γ=90.°
C14H19N2,C1N1S1
C14H19N2,C1N1S1
Acta Crystallographica Section B (1994) 50, 3 358-363
a=8.0608(9)Å b=22.941(3)Å c=8.266(2)Å
α=90.° β=90.° γ=90.°
Androst-4-ene-3,6,17-trione
C19H24O3
Acta Crystallographica Section C (1999) 55, 5 787-789
a=7.2842(6)Å b=13.4500(10)Å c=16.503(2)Å
α=90.00° β=90.00° γ=90.00°
1,1,1-tris(4-hydroxyphenyl)methane--bipyridine (1/1)
C19H16O3,C10H8N2
Acta Crystallographica Section C (2003) 59, 8 o481-o484
a=26.483(5)Å b=34.102(7)Å c=10.483(2)Å
α=90.00° β=90.00° γ=90.00°
Tris(4-hydroxyphenyl)methane
C19H16O3
Acta Crystallographica Section C (2003) 59, 8 o481-o484
a=12.326(3)Å b=18.573(4)Å c=7.4961(15)Å
α=90.00° β=114.36(3)° γ=90.00°
N-t-butoxycarbonyl-N-methyl-(O-benzyl)-L-tyrosine
C22H27NO5
Acta Crystallographica Section C (2002) 58, 6 o353-o354
a=9.346(2)Å b=11.413(2)Å c=19.493(4)Å
α=90.00° β=90.00° γ=90.00°